Guobing Xia
Papers
1
Total Citations
2
H-Index
1
About
Dr. Guobing Xia is a leading surgical oncologist whose research focuses on optimizing surgical approaches for hepatocellular carcinoma (HCC), particularly through comparative effectiveness studies. His major contributions center on evaluating robotic-assisted, laparoscopic, and open liver resection techniques for patients with early-stage (BCLC 0/A) HCC. In his landmark 2025 nationwide cohort study, Dr. Xia systematically compared clinical and economic outcomes across these three surgical modalities, providing critical evidence to guide treatment decisions in hepatectomy. This work has already garnered attention with 2 citations shortly after publication, reflecting its timely relevance to ongoing debates about the optimal surgical approach. Dr. Xia's research addresses the pressing need for high-quality, real-world data comparing minimally invasive techniques against traditional open surgery, helping surgeons and patients weigh trade-offs between recovery, oncologic outcomes, and healthcare costs. By leveraging large-scale national data, his findings offer actionable insights for clinical practice and healthcare policy. Dr. Xia continues to advance the field of hepatobiliary surgery through rigorous outcomes research that directly impacts surgical decision-making for one of the world's most common cancers.
Research Focus
Key Achievements
Top Papers
- 1